We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
At close: November 22 at 3:00 PM EST Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that ... about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis struck ...
Zacks.com on MSN1mon
Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory NewsThis week, Roche RHHBY announced its third ... while AstraZeneca has a Zacks Rank of 2 (Buy). You can see the complete list ...
Hosted on MSN6mon
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review TagRoche Holding AG RHHBY announced ... a Zacks Rank #4 (Sell). A better-ranked stock in the healthcare sector is Krystal Biotech, Inc. KRYS, carrying a Zacks Rank #2 (Buy) at present.
Investors looking for stocks in the Large Cap ... AG is sporting a Zacks Rank of #2 (Buy), while AbbVie has a Zacks Rank of #3 (Hold). This means that RHHBY's earnings estimate revision activity ...
1 Day RHHBY -0.59% DJIA 0.28% S&P 500 0.57% Health Care/Life Sciences 0.47% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback